In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Affidea also joins b-rayZ as a strategic investor, validating its vision, strengthening its market position and creating collaboration opportunities to drive innovation and growth ...

AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

Detailed price information for Treatment.com Ai Inc (TRUE-CN) from The Globe and Mail including charting and trades.

The alliance revolves around an AI-powered radiology analysis service for the development and evaluation of AI in medical imaging, with the aim of improving detection rates, speeding up treatment ...

The aim of the pilot is to scan and review more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance, to see if Qure.ai's qXR software can make faster and more ...

Glenmark Pharmaceuticals Ltd's shares soared over 14% after announcing a deal with AbbVie worth up to USD 2 billion. The ...

A technological revolution is unfolding — one that will transform our world in ways we can barely comprehend. As artificial ...

This week, our host Lauren Goode, along with two of our senior writers, Kate Knibbs and Paresh Dave, dive into the show’s ...

On a 48-hour mission to Egypt, renowned French haematologist and bone marrow transplant specialist Professor Jean-Henri ...